Cite
Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry.
MLA
Francica, Alessandra, et al. “Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry.” Transplant International : Official Journal of the European Society for Organ Transplantation, vol. 36, Sept. 2023, p. 11675. EBSCOhost, https://doi.org/10.3389/ti.2023.11675.
APA
Francica, A., Loforte, A., Attisani, M., Maiani, M., Iacovoni, A., Nisi, T., Comisso, M., Terzi, A., De Bonis, M., Vendramin, I., Boffini, M., Musumeci, F., Luciani, G. B., Rinaldi, M., Pacini, D., & Onorati, F. (2023). Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry. Transplant International : Official Journal of the European Society for Organ Transplantation, 36, 11675. https://doi.org/10.3389/ti.2023.11675
Chicago
Francica, Alessandra, Antonio Loforte, Matteo Attisani, Massimo Maiani, Attilio Iacovoni, Teodora Nisi, Marina Comisso, et al. 2023. “Five-Year Outcome After Continuous Flow LVAD With Full-Magnetic (HeartMate 3) Versus Hybrid Levitation System (HeartWare): A Propensity-Score Matched Study From an All-Comers Multicentre Registry.” Transplant International : Official Journal of the European Society for Organ Transplantation 36 (September): 11675. doi:10.3389/ti.2023.11675.